Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma
Clinical trial NCT02113436 · COMPLETED
Trial details
- NCT number
- NCT02113436
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2016-06-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.